RU2010130442A - METHOD FOR TUBERCULOSIS TREATMENT IN THE UNDERTAKENANCE OF TUBERCULOSIS CHEMOTHERAPY - Google Patents

METHOD FOR TUBERCULOSIS TREATMENT IN THE UNDERTAKENANCE OF TUBERCULOSIS CHEMOTHERAPY Download PDF

Info

Publication number
RU2010130442A
RU2010130442A RU2010130442/15A RU2010130442A RU2010130442A RU 2010130442 A RU2010130442 A RU 2010130442A RU 2010130442/15 A RU2010130442/15 A RU 2010130442/15A RU 2010130442 A RU2010130442 A RU 2010130442A RU 2010130442 A RU2010130442 A RU 2010130442A
Authority
RU
Russia
Prior art keywords
tuberculosis
chemotherapy
undertakenance
treatment
breakfast
Prior art date
Application number
RU2010130442/15A
Other languages
Russian (ru)
Other versions
RU2464034C2 (en
Inventor
Мария Константиновна Винокурова (RU)
Мария Константиновна Винокурова
Екатерина Сергеевна Павлова (RU)
Екатерина Сергеевна Павлова
Original Assignee
Государственное учреждение "Научно-практический центр "Фтизиатрия" Министерства здравоохранения республики Саха (Якутия) (RU)
Государственное учреждение "Научно-практический центр "Фтизиатрия" Министерства здравоохранения республики Саха (Якутия)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное учреждение "Научно-практический центр "Фтизиатрия" Министерства здравоохранения республики Саха (Якутия) (RU), Государственное учреждение "Научно-практический центр "Фтизиатрия" Министерства здравоохранения республики Саха (Якутия) filed Critical Государственное учреждение "Научно-практический центр "Фтизиатрия" Министерства здравоохранения республики Саха (Якутия) (RU)
Priority to RU2010130442/15A priority Critical patent/RU2464034C2/en
Publication of RU2010130442A publication Critical patent/RU2010130442A/en
Application granted granted Critical
Publication of RU2464034C2 publication Critical patent/RU2464034C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Способ лечения туберкулеза при непереносимости химиотерапии путем стандартной противотуберкулезной химиотерапии, отличающийся тем, что больным туберкулезом дополнительно назначают протеиновый концентрат «Протеины кедра» в дозе 15,0 г, растворенный в 150,0-200,0 мл воды, один раз в день через 1,5-2 ч после завтрака в течение 21 дня. A method of treating tuberculosis with chemotherapy intolerance by standard anti-tuberculosis chemotherapy, characterized in that tuberculosis patients are additionally prescribed protein concentrate “Cedar Proteins” at a dose of 15.0 g, dissolved in 150.0-200.0 ml of water, once a day every 1 5-2 hours after breakfast for 21 days.

Claims (1)

Способ лечения туберкулеза при непереносимости химиотерапии путем стандартной противотуберкулезной химиотерапии, отличающийся тем, что больным туберкулезом дополнительно назначают протеиновый концентрат «Протеины кедра» в дозе 15,0 г, растворенный в 150,0-200,0 мл воды, один раз в день через 1,5-2 ч после завтрака в течение 21 дня. A method of treating tuberculosis with chemotherapy intolerance by standard anti-tuberculosis chemotherapy, characterized in that tuberculosis patients are additionally prescribed protein concentrate “Cedar Proteins” at a dose of 15.0 g, dissolved in 150.0-200.0 ml of water, once a day every 1 5-2 hours after breakfast for 21 days.
RU2010130442/15A 2010-07-20 2010-07-20 Method of treating tuberculosis complicated by intolerance to chemotherapy RU2464034C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2010130442/15A RU2464034C2 (en) 2010-07-20 2010-07-20 Method of treating tuberculosis complicated by intolerance to chemotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010130442/15A RU2464034C2 (en) 2010-07-20 2010-07-20 Method of treating tuberculosis complicated by intolerance to chemotherapy

Publications (2)

Publication Number Publication Date
RU2010130442A true RU2010130442A (en) 2012-01-27
RU2464034C2 RU2464034C2 (en) 2012-10-20

Family

ID=45786224

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010130442/15A RU2464034C2 (en) 2010-07-20 2010-07-20 Method of treating tuberculosis complicated by intolerance to chemotherapy

Country Status (1)

Country Link
RU (1) RU2464034C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2314113C2 (en) * 2006-01-26 2008-01-10 Общество с ограниченной ответственностью "Биолит" Method for reducing adverse side effects in treating for tuberculosis
RU2347573C1 (en) * 2007-05-23 2009-02-27 Государственное образовательное учреждение высшего профессионального образования "Омская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО ОмГМА Росздрава) Method for correction of endogenuous intoxication and prevention of undesirable side reactions of antituberculous medications in tuberculosis patients

Also Published As

Publication number Publication date
RU2464034C2 (en) 2012-10-20

Similar Documents

Publication Publication Date Title
CY1124307T1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF THERAPY AND USES THEREOF
EA201892151A1 (en) METHOD OF SYNTHESIS 2-HYDROXY-6 - ((2- (1-IZOPROPIL-1H-PYRAZOL-5-IL) Pyridine-3-IL) METHOXY) BENZALDEHYDE
EA201692271A1 (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
RS53467B (en) Use of amisulpride for treating chemotherapy-induced nausea and vomiting
EA202090683A2 (en) METHODS AND COMPOSITIONS FOR CANCER TREATMENT
TR201909355T4 (en) Proton binding polymers for oral administration.
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
EA201792566A1 (en) SUBSTITUTED PHYLENOXAZOZOLIDINONES FOR ANTIMICROBIAL THERAPY
BR112015010039A2 (en) treatment of cancer with pomalidomide in an individual with renal dysfunction
BR112017011642A2 (en) compound, pharmaceutically acceptable salt, and method for treating a disease or condition that benefits from an increase in nad +.
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EP2579863A4 (en) Compounds for treatment of bovine mastitis
AR095594A1 (en) METHODS TO TREAT INFECTIONS IN PATIENTS WITH OVERWEIGHT AND OBESOS USING ANTIBIOTICS
RU2010130442A (en) METHOD FOR TUBERCULOSIS TREATMENT IN THE UNDERTAKENANCE OF TUBERCULOSIS CHEMOTHERAPY
AU2018288712A1 (en) Methods for treating merkel cell carcinoma (MCC) using NK-92 cells
EA201391335A1 (en) SUBSTITUTED DIPHENYL DERIVATIVES
MX2023005014A (en) Methods of treating chronic inflammatory diseases.
EA201990443A1 (en) NEW APPLICATION OF N, N-BIS-2 -MERCAPTOETHYLISOPHTHALAMIDE
BR112018070526A2 (en) Renal cell carcinoma treatment with lenvatinib and everolimus
MX2018001528A (en) Pharmaceutical composition comprising sumatripan for treating migraine.
RU2015109600A (en) A method for the comprehensive treatment of parasitic diseases of domestic reindeer
RU2014114347A (en) METHOD FOR INCREASING EFFICIENCY OF LEVOMYCETIN (CHLORAMPHENICOL)
RU2012106990A (en) METHOD FOR PREVENTION OF MYCOTOXICOSIS AND GASTROINTESTINAL DISEASES OF ANIMALS
EA201590325A1 (en) IMPROVED CANCER TREATMENT WITH REDUCED RENAL TOXICITY
RU2013130778A (en) METHOD FOR TREATING POST-DEGHELMINTIZATION HORSE DYSBACTERIOSIS

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20120721